Compounds > hydralazine
Page last updated: 2024-10-28

hydralazine and Esophageal Atresia

hydralazine has been researched along with Esophageal Atresia in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Esophageal Atresia: Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olson-Chen, C1
Seligman, NS1

Reviews

1 review available for hydralazine and Esophageal Atresia

ArticleYear
Hypertensive Emergencies in Pregnancy.
    Critical care clinics, 2016, Volume: 32, Issue:1

    Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; E

2016